F

FibroGen
D

FGEN

0.42830
USD
0.02
(5.18%)
Market Open
Volume
30,365
EPS
-1
Div Yield
-
P/E
-0
Market Cap
43,159,857
OverviewSignalsIdeasNews
Related Instruments
    ALNY
    ALNY
    -7.255
    (-2.96%)
    238.250 USD
    B
    BLUE
    -0.78000
    (-9.19%)
    7.71000 USD
    C
    CRSP
    -0.720
    (-1.77%)
    40.000 USD
    E
    EDIT
    -0.05500
    (-4.17%)
    1.26500 USD
    GILD
    GILD
    0.150
    (0.16%)
    92.720 USD
    I
    INCY
    0.040
    (0.06%)
    68.950 USD
    R
    RARE
    -1.030
    (-2.33%)
    43.160 USD
    REGN
    REGN
    8.19
    (1.17%)
    710.79 USD
    S
    SRPT
    -0.270
    (-0.23%)
    118.700 USD
    VRTX
    VRTX
    1.11
    (0.28%)
    398.47 USD
    More
News

Title: FibroGen

Sector: Healthcare
Industry: Biotechnology
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.